QLN
- Product code
- QLN
- Device name
- Extracorporeal System For Carbon Dioxide Removal For The Treatment Of Covid-19
- Device class
- Class N
- Medical specialty
- Unknown
- Marketing pathway
- EUA - Emergency Use Authorization
- Flag
- Life-sustaining / life-supporting
FDA classification definition
to treat lung failure due to COVID-19 when used as an adjunct to noninvasive or invasive mechanical ventilation in reducing hypercapnia and hypercapnic acidosis due to Coronavirus Disease 2019 (COVID-19), and/or maintaining normalized levels of partial pressure of carbon dioxide (PCO2) and pH in patients suffering from acute, reversible respiratory failure due to COVID-19 for whom ventilation of CO2 cannot be adequately, safely, or tolerably achieved.
Official FDA classification page: QLN
Classification and pathway per current FDA publications. Data from openFDA (CC0).